Mega Pharma SRL
The score of Mega Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +101 % Total assets +142 %
Accounts of the company itself (not consolidated).
The full file covers 4 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Mega Pharma's annual accounts
Filed annual accounts
- Year ended 30 Jun 2025filed on 21 Jan 2026
- Year ended 30 Jun 2024filed on 30 Jan 2025
- Year ended 30 Jun 2023filed on 31 Jan 2024
- Year ended 30 Jun 2022filed on 31 Jan 2023
Mega Pharma's financial analysis
- Solvency71.8%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Mega Pharma
Mega Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0760.552.551
- VAT number
- BE0760552551
- Peppol
- Registered · 0208:0760552551 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 24 Dec 2020
- Registered office
- 1785 Merchtem
- Latest accounts
- 2025 · filed on 21 Jan 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Mega Pharma (SRL) has been based in Merchtem since 2020, active in: retail sale of pharmaceutical products. For 2025, it reports a net loss of 2,092 € and equity of 107,902 €; its revenue is not published. Its solvency stands at 71.8%, above the median of its sector (44.2%).
Companies similar to Mega Pharma
Companies in the same business, of comparable size and area, outside its group.
- Cardio Control Retail sale of medical and orthopaedic goods Schilde · balance sheet 121,801 €
- Apotheek DE Scheerder Retail sale of pharmaceutical products Ghent · balance sheet 128,527 €
- Sivahe Retail sale of pharmaceutical products Hasselt · balance sheet 172,297 €
- MF Pharma Retail sale of pharmaceutical products Liège · balance sheet 96,029 €
- Lifetime Energy Retail sale of pharmaceutical products Wommelgem · balance sheet 287,751 €
- Caroline Vandierendonck Retail sale of pharmaceutical products Bree · balance sheet 115,934 €
- SRL Whisper Audition Retail sale of medical and orthopaedic goods Brussels · balance sheet 111,317 €
- Kourion.BE Retail sale of medical and orthopaedic goods Bertem · balance sheet 325,956 €
Frequently asked questions about Mega Pharma
What is the revenue of Mega Pharma?
Mega Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Mega Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0760552551 for Mega Pharma, if the company is VAT-registered. Its company number (CBE) is 0760.552.551.
Where is the registered office of Mega Pharma?
According to the CBE register, the registered office of Mega Pharma is in 1785 Merchtem.
What is the equity of Mega Pharma?
At the close of the 2025 financial year, the equity of Mega Pharma amounts to 107,902 €, a solvency of 71.8% of total assets.
Who manages Mega Pharma?
The register lists 1 active mandates at Mega Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Mega Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →